Real-time enrollment status for this friedreich ataxia clinical trial
Current Status
Recruiting
Checked: September 2, 2026 at 4:38 AM UTC
| NCT Number | NCT07721025 |
| Recruiting Status | Recruiting |
| Condition | Friedreich Ataxia |
| Phase | PHASE2 |
| Target Enrollment | 26 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Lexeo Therapeutics |
| Last Updated on CT.gov | July 22, 2026 (Jul 22, 2026) |
As of September 2, 2026: Clinical trial NCT07721025 is currently recruiting participants. This phase2 study for friedreich ataxia is actively seeking new participants at 1 location across the United States. The study is sponsored by Lexeo Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07721025 is actively recruiting participants as of September 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07721025 was last updated Jul 22, 2026 (July 22, 2026). HelloStudys verifies this status automatically.